Filter
1608
Filtered Results: 1608
Text search:
Ministry
of
Health,
Republic
of
South
Africa
Featured
Recommendations
126
New Publications
452
Language
Document type
No document type
928
Studies & Reports
346
Guidelines
151
Strategic & Response Plan
74
Manuals
65
Training Material
16
Situation Updates
16
Fact sheets
7
Infographics
3
App
1
Resource Platforms
1
Countries / Regions
Global
84
Kenya
63
Nigeria
57
Uganda
53
Ethiopia
52
Liberia
46
Africa
44
Congo, Democratic Republic of
43
Rwanda
40
Sierra Leone
39
Zambia
39
South Sudan
35
Tanzania
33
Malawi
32
South Africa
32
Namibia
32
Ghana
26
Lesotho
19
Guinea
18
Mozambique
18
Cameroon
17
Syria
17
East and Southern Africa
16
Western and Central Europe
15
Asia
14
Central African Republic
14
Myanmar / Burma
14
Latin America and the Carribbean
13
Botswana
12
India
12
Zimbabwe
11
Bangladesh
11
Senegal
10
West and Central Africa
10
Yemen
9
Benin
7
Afghanistan
7
Somalia
7
Eswatini/ Swaziland
7
Nepal
6
Burkina Faso
6
Sudan
6
Indonesia
6
Ukraine
5
Burundi
5
Middle East and North Africa
5
Mali
5
Angola
5
Colombia
4
Gambia
4
Togo
4
Haiti
4
Jordan
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Côte d’Ivoire / Ivory Coast
4
Iraq
4
Albania
3
Philippines
3
Cambodia
3
Guinea-Bissau
3
Mauritius
3
Brazil
3
Chad
3
Madagascar
3
Pakistan
3
Mexico
2
China
2
Iran
2
Venezuela
2
Germany
2
Jamaica
2
Southern Africa
2
Lebanon
2
Vietnam
2
Eastern Europe
2
Russia
2
Greece
2
Palestine
2
Libya
2
North Macedonia
1
Tajikistan
1
North Korea
1
Timor Leste/ East Timor
1
Thailand
1
Kazakhstan
1
Chile
1
Kyrgyzstan
1
Niger
1
Peru
1
Vanuatu
1
Morocco
1
Italy
1
Armenia
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
France
1
Tunisia
1
Bosnia and Herzegovina
1
Papua New Guinea
1
Moldova
1
Sri Lanka
1
Djibouti
1
Egypt
1
Georgia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
603
Clinical Guidelines
101
Women & Child Health
97
Public Health
94
Key Resources
86
Capacity Building
27
Pharmacy & Technologies
17
Toolboxes
HIV
159
Mental Health
114
COVID-19
104
TB
92
Rapid Response
65
Disability
61
Ebola & Marburg
60
Planetary Health
55
NTDs
55
Conflict
50
Caregiver
35
Refugee
34
Health Financing Toolbox
34
Global Health Education
34
AMR
26
Pharmacy
23
NCDs
17
Cholera
15
Natural Hazards
10
Polio
9
Zika
8
Specific Hazards
4
Social Ethics
3
South Sudan
2
Malaria
1
The WHO/IWA document A practical guide to auditing water safety plans provides guidance on developing and implementing a WSP auditing scheme, covering such topics as the aim and role of auditing, auditor training and certification, audit criteria, audit timing and frequency and audit reportin...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. The annual report provides an overview of the use and impact of the Fund over the previous year.
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
WHO guideline on contact tracing
recommended
This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated concepts. It allows for improvement of contact tracing strategies and provides recommendations attempting to answer some, though not all, questions that arose during t...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one health care-associated infection (HAI)...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during p...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during pregnan...
A resource for pesticide registrars and regulators.
The WHO urged governments to restrict access to highly toxic pesticides used for self-poisoning . Other effective interventions include education, youth intervention programs and follow-up of people at risk—and better data. Only 80 out of 183 WH...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h...
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals endorsed by the World Health Assembly. The plan sets out the: vision, goals and targets for the 2011-2020 period, recommended strategies, guiding princi...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
